JPMorgan Says Markets Are 'Extremely Risk-On'...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Morgan Stanley Stock Climbs: What's Happening Today?...
Goldman Sachs CEO Says AI Boom Is Still in the ‘Early Innings'...
IBM Heads for Worst Day Ever — But Why Are Cybersecurity Stocks Up?...
Shares of foundry, fabricator and IDM chip companies are trading higher after cooler June CPI data helped bring down bond yields and expectations for ...
Boeing Boosts Momentum With Strong Q2 Jet and Defense Deliveries...
Palo Alto Stock Rises After IBM's Cybersecurity Warning...
JPMorgan Says Coinbase, Circle Are in a 'Prisoner's Dilemma' Over Hyperliquid Partnership...
Bank Earnings Indicate Strong Economy; IBM Drops Dragging Software; Warsh Says No Tolerance For Inflation...
ASML Could Swing 7.5% After Earnings on Wednesday...
'Goldman Raises $10 Billion From Latest High-Grade Bond Sale' - Bloomberg...
IBM Says AI Spending Isn't Crowding Out Cybersecurity. These ETFs Are Gaining Momentum...
'OpenAI’s First Device Will Be Moveable, Screenless Speaker Built as AI Companion'- Bloomberg...
Chamath Palihapitiya on IBM Stock Drop, AI Spending Concerns: ‘You’re Starting to See a Little Bit of the Wheels Come Off’...
Olive Garden Follows McDonald’s Bet on Value: Will Never Ending Pasta Pass Strategy Work?...
On July 14, 2026, Apotex received FDA approval for ANDA 210725, positioning the company to enter the [Insert Substance] market immediately following t...
Camber Pharmaceuticals, Inc. has secured FDA approval for the ANDA for afatinib dimaleate, which positions the company to enter the oral anticancer ma...
The FDA has granted approval to CELCUITY for its novel oral anti-cancer agent, set to launch on July 14, 2026. This strategic development positions th...
On July 14, 2026, Anthela Pharma obtained regulatory approval for an application bearing index number ANDA220857, signaling a new entry into the marke...
Institutional holdings report (13F-HR) filed by Wall Street Financial Group, Inc.....